Home
electronic Physician Global Assessment for Psoriasis
ePGA for Psoriasis
Assessment of psoriasis severity made easy and quick
What is the ePGA for Psoriasis?
The electronic Physician Global Assessment (ePGA) is a 5- or sometimes 6-point scoring system used to assess the severity of psoriasis. The terms physician or investigator global assessment may be used interchangeably. The PGA is used as a global static assessment of all lesions and gives a general impression of the severity or improvement of psoriasis over time. The PGA was originally developed to measure disease severity within clinical trials and is one of the standard parameters gathered to assess treatment success. In recent years, the PGA has become more commonly used in clinical practice to guide treatment decisions for physicians and document the impact of clinical treatment over time.
Validation of questionnaire
paper version: yes digital version: no
How to use the ePGA for Psoriasis
The ePGA should only be used by trained physicians. The score is measured by the number and severity of lesion induration, erythema and scale and ranges from 0 - clear to 4 - severe. Each severity grade is distinctly defined by a relevant morphologic description to ensure comparability of ePGA scores between health care providers and over time.
The following versions of the ePGA for Psoriasis are available
Features
USER-FRIENDLY
The ePGA is easy and straightforward to use, thanks to the clear morphological description of the severity states.
SEVERITY MONITORING
By storing values, the ePGA allows for easy monitoring of psoriasis.
ENVIRONMENTALLY FRIENDLY
Take care of the environment and save your patient data on the online platform or as PDF files for yourself and your physicians.
ACCURATE
The ePGA is recommended by international guideline associations for an accurate measurement of severity of psoriasis.
ACCESSIBLE FROM ALL DEVICES
With DermaValue, your ePGA is always just a few clicks away. The application is available for PCs, tablets, smartphones, and other devices.
MULTILINGUAL
The ePGA is available in different languages. The use of the respective first language reduces language barriers and supports the understanding between physician and patient.
References
Validation study:
Weisman, S., Pollack, C. R., & Gottschalk, R. W. (2003). Psoriasis disease severity measures: comparing efficacy of treatments for severe psoriasis. The Journal of dermatological treatment, 14(3), 158–165. https://doi.org/10.1080/09546630310013360
Pascoe VL, Enamandram M, Corey KC, et al. Using the Physician Global Assessment in a Clinical Setting to Measure and Track Patient Outcomes. JAMA Dermatol. 2015;151(4):375–381. doi:10.1001/jamadermatol.2014.3513
Our other tools
Our partners
